Overview
Medtronic plc is a globally recognized medical device company based in Dublin, Ireland. It primarily operates in the healthcare sector, focusing on the development, manufacturing, and sales of device-based medical therapies. Its diversified product portfolio addresses a wide range of chronic diseases including cardiac and vascular diseases, respiratory, neurological, and spinal conditions, among others. Medtronic is particularly noted for its contributions to diabetes management, heart therapies, and minimally invasive therapies. The company undertakes significant research and development efforts, evident from its robust pipeline of innovative medical technologies aimed at improving patient outcomes and expanding global access to healthcare. Medtronic's strategic projects often involve collaborations with health professionals and institutions to advance medical science and the application of technology in medicine.
AI+ Ask Fintel’s AI assistant about Medtronic plc.
Thinking about good questions…
Basic Stats
The share price of Medtronic plc as of 10 July 2025 is € 77,03 / share. The market cap (or net worth) of Medtronic plc as of 10 July 2025 is € 98.747,42 MM.
The Factor Analysis chart (below right) shows a view of Medtronic plc from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.
For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.
| Market Cap | 98,747.42 MM |
| EV | |
| Shares Out. | 1,281.93 MM |
| Earnings Date | |
| EPS (TTM) | 3.64 |
| Dividend Yield | |
| Ex-Dividend Date | 2025-09-26 |
| Borrow Rate | |
| Short Shares Avail. | |
| Short Interest | |
| Short Float | |
| Days to Cover | |
| Risk Free Rate | 4.17 % |
| Price Change (1 yr) | |
| Volatility (1 yr) | 0.08 |
| Beta | 1.44 |
| Sharpe Ratio (1 yr) | |
| Sortino Ratio (1 yr) |
| PE Ratio | |
| Price/Book | |
| Price/TBV | |
| Book/Market | |
| EBIT/EV | |
| EBIT(3yr avg)/EV | |
| ROA | 0.05 |
| ROE | 0.09 |
| ROIC | 0.06 |
| CROIC | 0.01 |
| OCROIC | 0.09 |
| Implied Volatility | |
| Put/Call OI Ratio |
| Growth | |
| Profitability | |
| Quality Score | |
| Value Score | |
| Momentum Score | |
| Stability (Low Vol) Score | 96.80 /100 |
| Analyst Sentiment | |
| Fund Sentiment | |
| Insider Sentiment | |
| Officer Sentiment | |
| Dividend Score | |
| QVM Score | |
| Piotroski F-SCORE | 6.00 /9 |
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Price Target
The average one-year price target for Medtronic plc is € 111,58. The forecasts range from a low of € 85,85 to a high of € 149,42. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their buy or sell recommendations.
Update Frequency: Monthly
| Record Date | Projection Date | High | Low | Median | Average |
|---|---|---|---|---|---|
| 2023-12-20 | 2024-12-20 | 149.42 | 85.85 | 109.14 | 111.58 |
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for Medtronic plc. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:
- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
| Date | Analyst | Prior | Latest Recommendation |
Action |
|---|---|---|---|---|
| 2024-07-16 | Truist Securities | Hold | Hold | Maintains |
| 2024-07-10 | Citigroup | Neutral | Neutral | Maintains |
| 2024-06-05 | RBC Capital | Sector Perform | Sector Perform | Reiterate |
| 2024-05-30 | Goldman Sachs | Sell | Initiate | |
| 2024-05-24 | RBC Capital | Sector Perform | Sector Perform | Reiterate |
| 2024-05-24 | Wells Fargo | Overweight | Overweight | Maintains |
| 2024-05-24 | Truist Securities | Hold | Hold | Maintains |
| 2024-05-24 | UBS | Sell | Sell | Maintains |
| 2024-05-24 | Needham | Hold | Reiterate | |
| 2024-02-21 | Oppenheimer | Perform | Perform | Maintains |
| 2024-02-21 | RBC Capital | Sector Perform | Sector Perform | Reiterate |
| 2024-02-21 | Mizuho | Buy | Buy | Maintains |
| 2024-02-21 | Truist Securities | Hold | Hold | Maintains |
| 2024-01-12 | RBC Capital | Sector Perform | Sector Perform | Maintains |
| 2023-12-22 | Truist Securities | Hold | Hold | Maintains |
| 2023-11-22 | RBC Capital | Sector Perform | Sector Perform | Reiterate |
| 2023-11-22 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2023-08-23 | RBC Capital | Sector Perform | Sector Perform | Reiterate |
| 2023-08-23 | Oppenheimer | Perform | Perform | Reiterate |
| 2023-08-23 | UBS | Sell | Sell | Maintains |
| 2023-08-23 | Mizuho | Buy | Buy | Maintains |
| 2023-08-23 | Wells Fargo | Overweight | Overweight | Maintains |
| 2023-08-23 | Stifel | Buy | Buy | Maintains |
| 2023-07-19 | Baird | Neutral | Initiate | |
| 2023-06-30 | CL King | Buy | Initiate | |
| 2023-05-26 | RBC Capital | Sector Perform | Sector Perform | Reiterate |
| 2023-05-26 | Truist Securities | Hold | Hold | Maintains |
| 2023-05-26 | Stifel | Buy | Buy | Maintains |
| 2023-05-26 | Bernstein | Outperform | Outperform | Maintains |
| 2023-05-25 | Evercore ISI Group | Outperform | Maintains | |
| 2023-04-24 | Barclays | Equal-Weight | Overweight | Upgrade |
| 2023-04-24 | Truist Securities | Hold | Maintains | |
| 2023-04-24 | Wells Fargo | Equal-Weight | Overweight | Upgrade |
| 2023-04-21 | RBC Capital | Sector Perform | Reiterate | |
| 2023-04-17 | Truist Securities | Hold | Maintains | |
| 2023-01-24 | Mizuho | Buy | Maintains | |
| 2023-01-09 | RBC Capital | Outperform | Sector Perform | Downgrade |
| 2022-11-30 | Wells Fargo | Equal-Weight | Maintains | |
| 2022-11-25 | Barclays | Equal-Weight | Maintains | |
| 2022-11-23 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-11-23 | Oppenheimer | Outperform | Perform | Downgrade |
| 2022-11-23 | RBC Capital | Outperform | Maintains | |
| 2022-11-23 | Citigroup | Buy | Neutral | Downgrade |
| 2022-10-18 | Barclays | Equal-Weight | Initiate | |
| 2022-10-17 | Truist Securities | Hold | Maintains | |
| 2022-10-13 | Mizuho | Buy | Initiate | |
| 2022-10-12 | Jefferies | Hold | Initiate | |
| 2022-10-11 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-09-07 | RBC Capital | Outperform | Maintains | |
| 2022-08-24 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-08-24 | Wells Fargo | Equal-Weight | Maintains | |
| 2022-08-24 | Raymond James | Outperform | Market Perform | Downgrade |
| 2022-07-20 | Truist Securities | Hold | Maintains | |
| 2022-07-18 | Stifel | Buy | Maintains | |
| 2022-07-15 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-07-06 | Wolfe Research | Underperform | Initiate | |
| 2022-06-07 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-06-01 | Atlantic Equities | Overweight | Neutral | Downgrade |
| 2022-05-31 | Truist Securities | Hold | Maintains | |
| 2022-05-31 | Raymond James | Outperform | Maintains | |
| 2022-05-27 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-05-27 | Deutsche Bank | Buy | Maintains | |
| 2022-05-27 | RBC Capital | Outperform | Maintains | |
| 2022-05-27 | Cowen & Co. | Outperform | Maintains | |
| 2022-05-27 | Citigroup | Buy | Maintains | |
| 2022-05-27 | Needham | Buy | Hold | Downgrade |
| 2022-05-27 | Piper Sandler | Neutral | Maintains | |
| 2022-05-23 | Cowen & Co. | Outperform | Maintains | |
| 2022-05-17 | Citigroup | Buy | Maintains | |
| 2022-02-23 | Credit Suisse | Outperform | Maintains | |
| 2022-02-23 | Needham | Buy | Maintains | |
| 2022-02-18 | Raymond James | Outperform | Maintains | |
| 2022-02-16 | Piper Sandler | Neutral | Maintains | |
| 2022-01-25 | Needham | Buy | Maintains | |
| 2022-01-21 | SVB Leerink | Market Perform | Maintains | |
| 2022-01-19 | Citigroup | Buy | Maintains | |
| 2022-01-18 | Goldman Sachs | Neutral | Maintains | |
| 2022-01-10 | BTIG | Buy | Neutral | Downgrade |
| 2022-01-07 | Morgan Stanley | Overweight | Equal-Weight | Downgrade |
| 2022-01-04 | Piper Sandler | Overweight | Neutral | Downgrade |
| 2021-12-21 | Truist Securities | Buy | Maintains | |
| 2021-12-20 | Credit Suisse | Outperform | Maintains | |
| 2021-12-17 | Oppenheimer | Outperform | Maintains | |
| 2021-12-17 | BTIG | Buy | Maintains | |
| 2021-12-17 | JP Morgan | Overweight | Neutral | Downgrade |
| 2021-12-16 | Wells Fargo | Overweight | Equal-Weight | Downgrade |
| 2021-12-16 | Needham | Buy | Maintains | |
| 2021-12-10 | RBC Capital | Outperform | Initiate | |
| 2021-11-24 | Citigroup | Buy | Maintains | |
| 2021-11-24 | Morgan Stanley | Overweight | Maintains | |
| 2021-11-24 | Wells Fargo | Overweight | Maintains | |
| 2021-11-24 | Oppenheimer | Outperform | Maintains | |
| 2021-11-23 | Needham | Buy | Maintains | |
| 2021-10-18 | Wells Fargo | Overweight | Maintains | |
| 2021-08-27 | Argus Research | Buy | Maintains | |
| 2021-08-25 | Truist Securities | Buy | Maintains | |
| 2021-08-25 | UBS | Buy | Maintains | |
| 2021-08-25 | Citigroup | Buy | Maintains | |
| 2021-08-25 | Stifel | Buy | Maintains | |
| 2021-08-25 | Morgan Stanley | Overweight | Maintains | |
| 2021-08-25 | Raymond James | Outperform | Maintains | |
| 2021-08-25 | Wells Fargo | Overweight | Maintains | |
| 2021-08-25 | Credit Suisse | Outperform | Maintains | |
| 2021-06-03 | Argus Research | Buy | Maintains | |
| 2021-05-28 | Citigroup | Buy | Maintains | |
| 2021-05-28 | Oppenheimer | Outperform | Maintains | |
| 2021-05-28 | Deutsche Bank | Buy | Maintains | |
| 2021-05-28 | SVB Leerink | Market Perform | Maintains | |
| 2021-05-28 | Raymond James | Outperform | Maintains | |
| 2021-05-25 | Barclays | Equal-Weight | Initiate | |
| 2021-04-15 | Atlantic Equities | Overweight | Initiate | |
| 2021-02-24 | Stifel | Buy | Maintains | |
| 2021-02-24 | SVB Leerink | Market Perform | Maintains | |
| 2021-02-24 | Credit Suisse | Outperform | Maintains | |
| 2021-02-24 | Raymond James | Outperform | Maintains | |
| 2020-12-15 | Morgan Stanley | Equal-Weight | Overweight | Upgrade |
| 2020-11-25 | Credit Suisse | Outperform | Maintains | |
| 2020-11-25 | Morgan Stanley | Equal-Weight | Maintains | |
| 2020-11-25 | UBS | Buy | Maintains | |
| 2020-11-25 | Raymond James | Outperform | Maintains | |
| 2020-11-25 | SVB Leerink | Market Perform | Maintains | |
| 2020-11-18 | Wells Fargo | Overweight | Maintains | |
| 2020-10-15 | Jefferies | Buy | Maintains | |
| 2020-10-08 | Stifel | Hold | Buy | Upgrade |
| 2020-09-24 | Truist Securities | Buy | Maintains | |
| 2020-09-11 | Wolfe Research | Peer Perform | Initiate | |
| 2020-08-26 | BTIG | Buy | Maintains | |
| 2020-08-26 | SVB Leerink | Market Perform | Maintains | |
| 2020-08-26 | Morgan Stanley | Equal-Weight | Maintains | |
| 2020-08-26 | Credit Suisse | Outperform | Maintains | |
| 2020-08-26 | Citigroup | Buy | Maintains | |
| 2020-08-26 | Raymond James | Outperform | Maintains | |
| 2020-08-25 | Needham | Buy | Maintains | |
| 2020-05-22 | Morgan Stanley | Equal-Weight | Maintains | |
| 2020-05-22 | Raymond James | Outperform | Maintains | |
| 2020-05-22 | Deutsche Bank | Buy | Maintains | |
| 2020-05-22 | Jefferies | Buy | Maintains | |
| 2020-05-22 | Oppenheimer | Outperform | Maintains | |
| 2020-05-22 | UBS | Buy | Maintains | |
| 2020-05-22 | Piper Sandler | Overweight | Maintains | |
| 2020-05-21 | CFRA | Buy | Strong Buy | Upgrade |
| 2020-05-14 | DZ Bank | Buy | Hold | Downgrade |
| 2020-04-28 | SVB Leerink | Market Perform | Maintains | |
| 2020-04-09 | JP Morgan | Overweight | Maintains | |
| 2020-03-30 | Needham | Strong Buy | Buy | Downgrade |
| 2020-03-30 | BTIG | Buy | Maintains | |
| 2020-03-27 | Citigroup | Buy | Maintains | |
| 2020-03-27 | Morgan Stanley | Equal-Weight | Maintains | |
| 2020-03-25 | DZ Bank | Hold | Buy | Upgrade |
| 2020-03-06 | Credit Suisse | Outperform | Maintains | |
| 2020-03-05 | Citigroup | Buy | Initiate | |
| 2020-02-19 | BTIG Research | Buy | Maintains | |
| 2020-02-19 | Raymond James | Outperform | Maintains | |
| 2020-02-18 | CFRA | Buy | Maintains | |
| 2020-02-13 | Goldman Sachs | Sell | Initiate | |
| 2020-01-22 | Piper Sandler | Overweight | Maintains | |
| 2020-01-16 | UBS | Buy | Maintains | |
| 2020-01-08 | SunTrust Robinson Humphrey | Buy | Initiate | |
| 2020-01-02 | Guggenheim Securities | Neutral | Buy | Upgrade |
| 2019-12-20 | JP Morgan | Overweight | Maintains | |
| 2019-12-17 | Morgan Stanley | Equal-Weight | Maintains | |
| 2019-11-20 | RBC Capital | Outperform | Maintains | |
| 2019-11-20 | Raymond James | Outperform | Maintains | |
| 2019-11-20 | Deutsche Bank | Buy | Maintains | |
| 2019-11-20 | Oppenheimer | Outperform | Maintains | |
| 2019-08-21 | Deutsche Bank | Buy | Maintains | |
| 2019-08-21 | BMO Capital | Outperform | Reiterate | |
| 2019-08-21 | Barclays | Overweight | Maintains | |
| 2019-08-21 | Morgan Stanley | Equal-Weight | Maintains | |
| 2019-08-21 | Stifel Nicolaus | Hold | Maintains | |
| 2019-08-21 | UBS | Buy | Maintains | |
| 2019-08-21 | Wells Fargo | Outperform | Maintains | |
| 2019-08-21 | Raymond James | Outperform | Maintains | |
| 2019-08-19 | Deutsche Bank | Buy | Maintains | |
| 2019-08-14 | Morgan Stanley | Equal-Weight | Maintains | |
| 2019-06-05 | Wells Fargo | Market Perform | Outperform | Upgrade |
| 2019-04-04 | Wells Fargo | Market Perform | Market Perform | Maintains |
| 2019-02-25 | Citigroup | Neutral | Neutral | Maintains |
| 2019-01-15 | BTIG Research | Neutral | Buy | Upgrade |
| 2019-01-08 | Barclays | Overweight | Overweight | Maintains |
| 2019-01-03 | Deutsche Bank | Buy | Initiate | |
| 2019-01-02 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2019-01-02 | Citigroup | Buy | Neutral | Downgrade |
| 2018-12-19 | JP Morgan | Neutral | Overweight | Upgrade |
| 2018-12-17 | Credit Suisse | Outperform | Initiate | |
| 2018-11-28 | UBS | Buy | Initiate | |
| 2018-11-21 | Raymond James | Outperform | Outperform | Maintains |
| 2018-10-16 | Barclays | Overweight | Initiate | |
| 2018-10-08 | Argus | Buy | Buy | Maintains |
| 2018-08-27 | Argus | Buy | Buy | Maintains |
| 2018-08-24 | Citigroup | Buy | Buy | Maintains |
| 2018-08-22 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2018-08-22 | Bank of America | Buy | Buy | Maintains |
| 2018-08-22 | BMO Capital | Outperform | Outperform | Maintains |
| 2018-08-22 | Wells Fargo | Market Perform | Market Perform | Maintains |
| 2018-08-22 | Stifel Nicolaus | Hold | Hold | Maintains |
| 2018-08-13 | Needham | Buy | Strong Buy | Upgrade |
| 2018-06-27 | Bernstein | Market Perform | Initiate | |
| 2018-05-31 | Raymond James | Outperform | Initiate | |
| 2018-05-25 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2018-03-29 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2018-02-22 | Citigroup | Buy | Buy | Maintains |
| 2018-02-05 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2018-01-03 | Evercore ISI Group | Outperform | Initiate | |
| 2018-01-02 | Bank of America | Neutral | Buy | Upgrade |
| 2017-12-12 | Argus | Hold | Buy | Upgrade |
| 2017-10-10 | BMO Capital | Outperform | Maintains | |
| 2017-10-09 | Leerink Swann | Market Perform | Maintains | |
| 2017-10-09 | Wells Fargo | Outperform | Market Perform | Downgrade |
| 2017-08-23 | Barclays | Overweight | Maintains | |
| 2017-08-23 | Jefferies | Buy | Maintains | |
| 2017-07-10 | Morgan Stanley | Equal-Weight | Maintains | |
| 2017-05-16 | Goldman Sachs | Neutral | Initiate | |
| 2017-01-03 | Morgan Stanley | Overweight | Equal-Weight | Downgrade |
| 2017-01-03 | JP Morgan | Overweight | Neutral | Downgrade |
| 2016-11-23 | Barclays | Overweight | Maintains | |
| 2016-11-23 | Oppenheimer | Outperform | Maintains | |
| 2016-11-23 | Jefferies | Buy | Maintains | |
| 2016-11-23 | BMO Capital | Outperform | Maintains | |
| 2016-08-26 | UBS | Buy | Maintains | |
| 2016-08-26 | Jefferies | Buy | Maintains | |
| 2016-08-23 | Citigroup | Buy | Initiate | |
| 2016-06-13 | SunTrust Robinson Humphrey | Buy | Maintains | |
| 2016-06-09 | Guggenheim | Neutral | Initiate | |
| 2016-06-02 | Deutsche Bank | Buy | Maintains | |
| 2016-06-01 | BTIG Research | Buy | Neutral | Downgrade |
| 2016-04-25 | SunTrust Robinson Humphrey | Buy | Initiate | |
| 2016-03-17 | Nomura | Buy | Initiate | |
| 2016-03-02 | Morgan Stanley | Overweight | Maintains | |
| 2016-03-02 | JP Morgan | Overweight | Maintains | |
| 2015-11-23 | Credit Suisse | Outperform | Maintains | |
| 2015-10-08 | Evercore ISI Group | Hold | Buy | Upgrade |
| 2015-09-04 | Jefferies | Hold | Maintains | |
| 2015-09-02 | Cowen & Co. | Outperform | Maintains | |
| 2015-07-16 | BTIG Research | Neutral | Buy | Upgrade |
| 2015-03-16 | BMO Capital | Outperform | Maintains | |
| 2015-02-18 | Jefferies | Buy | Maintains | |
| 2014-12-05 | Bank of America | Buy | Maintains | |
| 2014-11-19 | Wedbush | Neutral | Maintains | |
| 2014-11-19 | Jefferies | Buy | Maintains | |
| 2014-11-13 | JP Morgan | Overweight | Maintains | |
| 2014-09-30 | Needham | Buy | Initiate | |
| 2014-09-11 | Sterne Agee | Neutral | Initiate | |
| 2014-08-20 | Citigroup | Buy | Maintains | |
| 2014-08-18 | Citigroup | Buy | Maintains | |
| 2014-06-20 | Jefferies | Hold | Buy | Upgrade |
| 2014-06-18 | Barclays | Equal-Weight | Overweight | Upgrade |
| 2014-06-17 | Deutsche Bank | Buy | Maintains | |
| 2014-06-17 | BTIG Research | Neutral | Buy | Upgrade |
| 2014-06-17 | Credit Suisse | Neutral | Outperform | Upgrade |
| 2014-06-17 | Morgan Stanley | Equal-weight | Overweight | Upgrade |
| 2014-06-17 | RBC Capital | Sector Perform | Outperform | Upgrade |
| 2014-06-16 | JP Morgan | Neutral | Overweight | Upgrade |
| 2014-06-16 | William Blair | Market Perform | Outperform | Upgrade |
| 2014-05-21 | Deutsche Bank | Buy | Maintains | |
| 2014-05-21 | Citigroup | Buy | Maintains | |
| 2014-05-19 | Credit Suisse | Neutral | Maintains | |
| 2014-04-15 | JP Morgan | Overweight | Neutral | Downgrade |
| 2014-04-14 | Bank of America | Buy | Maintains | |
| 2014-04-07 | Citigroup | Buy | Maintains | |
| 2014-03-31 | Bank of America | Buy | Maintains | |
| 2014-03-27 | Citigroup | Buy | Maintains | |
| 2014-01-08 | BTIG Research | Neutral | Initiate | |
| 2014-01-06 | JP Morgan | Neutral | Overweight | Upgrade |
| 2013-12-17 | Goldman Sachs | Neutral | Buy | Upgrade |
| 2013-11-21 | Citigroup | Buy | Maintains | |
| 2013-11-20 | Argus | Buy | Hold | Downgrade |
| 2013-11-20 | PiperJaffray | Overweight | Maintains | |
| 2013-11-20 | Jefferies | Hold | Maintains | |
| 2013-11-20 | JP Morgan | Neutral | Maintains | |
| 2013-10-23 | Deutsche Bank | Hold | Buy | Upgrade |
| 2013-08-22 | Deutsche Bank | Hold | Maintains | |
| 2013-08-21 | Jefferies | Hold | Maintains | |
| 2013-08-16 | Credit Suisse | Neutral | Maintains | |
| 2013-05-31 | Wedbush | Neutral | Initiate | |
| 2013-05-22 | Jefferies | Hold | Maintains | |
| 2013-05-22 | Wunderlich | Hold | Maintains | |
| 2013-05-16 | Credit Suisse | Neutral | Outperform | Upgrade |
| 2013-04-12 | Deutsche Bank | Hold | Maintains | |
| 2013-02-20 | Barclays | Equal-Weight | Maintains | |
| 2013-02-20 | Jefferies | Hold | Maintains | |
| 2013-02-20 | BMO Capital | Outperform | Maintains | |
| 2013-02-19 | PiperJaffray | Overweight | Maintains | |
| 2013-02-14 | Lazard | Buy | Neutral | Downgrade |
| 2013-01-25 | Wunderlich | Buy | Hold | Downgrade |
| 2013-01-17 | Credit Suisse | Neutral | Outperform | Upgrade |
| 2013-01-04 | Deutsche Bank | Hold | Maintains | |
| 2013-01-03 | Mizuho | Neutral | Buy | Upgrade |
| 2012-11-23 | Deutsche Bank | Hold | Maintains | |
| 2012-11-21 | Deutsche Bank | Hold | Maintains | |
| 2012-11-21 | Credit Suisse | Neutral | Maintains | |
| 2012-11-20 | Stifel Nicolaus | Hold | Initiate | |
| 2012-09-20 | UBS | Buy | Maintains | |
| 2012-08-22 | Jefferies | Hold | Maintains | |
| 2012-08-22 | Barclays | Equal-Weight | Maintains | |
| 2012-08-22 | Goldman Sachs | Neutral | Maintains | |
| 2012-08-22 | PiperJaffray | Overweight | Maintains | |
| 2012-08-22 | Citigroup | Buy | Maintains | |
| 2012-08-22 | Deutsche Bank | Hold | Maintains | |
| 2012-06-04 | BMO Capital | Outperform | Maintains | |
| 2012-05-31 | UBS | Buy | Maintains | |
| 2012-05-18 | Citigroup | Buy | Maintains | |
| 2012-05-14 | Citigroup | Buy | Maintains | |
| 2012-04-05 | Bank oferica | Buy | Maintains | |
| 2012-02-22 | Brean Capital | Buy | Maintains | |
| 2012-02-10 | Citigroup | Buy | Maintains | |
| 2025-02-19 | RBC Capital | Outperform | Outperform | Reiterate |
| 2025-02-19 | UBS | Neutral | Neutral | Maintains |
| 2025-02-19 | Baird | Neutral | Neutral | Maintains |
| 2025-02-19 | Needham | Hold | Hold | Reiterate |
| 2024-08-14 | Stifel | Buy | Hold | Downgrade |
| 2024-07-17 | RBC Capital | Sector Perform | Sector Perform | Reiterate |
| 2024-10-01 | Citigroup | Neutral | Neutral | Maintains |
| 2024-10-01 | Evercore ISI Group | Outperform | Outperform | Maintains |
| 2024-08-21 | Oppenheimer | Perform | Perform | Maintains |
| 2024-08-21 | Piper Sandler | Neutral | Neutral | Maintains |
| 2024-08-21 | RBC Capital | Sector Perform | Sector Perform | Reiterate |
| 2024-08-21 | Wells Fargo | Overweight | Overweight | Maintains |
| 2024-08-21 | Baird | Neutral | Neutral | Maintains |
| 2024-08-21 | Stifel | Hold | Hold | Maintains |
| 2024-11-26 | Barclays | Overweight | Overweight | Maintains |
| 2024-08-22 | Barclays | Overweight | Overweight | Maintains |
| 2024-08-15 | UBS | Sell | Neutral | Upgrade |
| 2025-04-11 | Truist Securities | Hold | Hold | Maintains |
| 2024-10-25 | Needham | Hold | Reiterate | |
| 2024-11-18 | Needham | Hold | Reiterate | |
| 2024-12-18 | Truist Securities | Hold | Hold | Maintains |
| 2024-08-23 | Truist Securities | Hold | Hold | Maintains |
| 2024-10-08 | RBC Capital | Sector Perform | Sector Perform | Maintains |
| 2025-02-12 | Needham | Hold | Hold | Reiterate |
| 2024-10-14 | Truist Securities | Hold | Hold | Maintains |
| 2024-08-12 | Needham | Hold | Reiterate | |
| 2024-11-20 | Bernstein | Outperform | Outperform | Maintains |
| 2024-11-20 | Wells Fargo | Overweight | Overweight | Maintains |
| 2024-11-20 | Baird | Neutral | Neutral | Maintains |
| 2024-11-20 | Needham | Hold | Reiterate | |
| 2025-05-22 | Needham | Hold | Hold | Reiterate |
| 2024-10-10 | RBC Capital | Sector Perform | Outperform | Upgrade |
| 2025-03-04 | Citigroup | Neutral | Buy | Upgrade |
| 2024-08-20 | Needham | Hold | Reiterate | |
| 2025-07-16 | Mizuho | Outperform | Outperform | Maintains |
| 2025-07-09 | Citigroup | Buy | Buy | Maintains |
| 2025-08-21 | Truist Securities | Hold | Hold | Maintains |
| 2025-08-21 | Citigroup | Buy | Buy | Maintains |
| 2025-05-22 | Baird | Neutral | Neutral | Maintains |
| 2025-05-22 | RBC Capital | Outperform | Outperform | Maintains |
| 2025-05-22 | Mizuho | Outperform | Outperform | Maintains |
| 2025-08-14 | Needham | Hold | Hold | Reiterate |
| 2025-06-06 | Needham | Hold | Hold | Reiterate |
| 2025-05-19 | Needham | Hold | Hold | Reiterate |
| 2025-06-16 | Leerink Partners | Outperform | Initiate | |
| 2025-06-30 | Wolfe Research | Underperform | Peer Perform | Upgrade |
| 2025-07-15 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2025-08-26 | Argus Research | Buy | Buy | Maintains |
| 2025-08-20 | UBS | Neutral | Neutral | Maintains |
| 2025-08-20 | Wells Fargo | Overweight | Overweight | Maintains |
| 2025-08-20 | Baird | Neutral | Neutral | Maintains |
| 2025-08-20 | Bernstein | Outperform | Outperform | Maintains |
| 2025-07-08 | Evercore ISI Group | Outperform | Outperform | Maintains |
